It was reported that the abnormal activation of STAT and interferon regulatory transcription factor (IRF) signaling pathways is involved in various human diseases (including cardiovascular diseases), consequently attracting attention as highly interesting therapeutic targets (7, 8). Here, SOAT1 is linked to cardiovascular disorder.